-
Mashup Score: 2Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence - 1 month(s) ago
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation - 2 month(s) ago
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Portal vein thrombosis rates higher after TACE, but ‘negligible’ effect on clinical course - 3 month(s) ago
Incidence of new portal vein thrombosis was higher after transarterial chemoembolization for hepatocellular carcinoma compared with microwave or radiofrequency ablation, although researchers reported no clinically significant sequalae. “Transarterial chemoembolization (TACE) is recommended for patients with asymptomatic, large or multifocal HCC without extrahepatic metastases,” Marisa
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0ESMO Preceptorship on Hepatocellular Carcinoma 2023: Madrid - 7 month(s) ago
15-16 December 2023
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Applications open for the #ESMOPreceptorship on #HepatocellularCarcinoma 👉 looking into best clinical practice, best tx according to radiological staging, tx sequencing, & more. Apply here: https://t.co/TZrcMUtQty #LiverCancer @ArndtVogel @erikamartin3lli @LorenzaRimassa #HCC https://t.co/bi7vqVhXVu
-
-
Mashup Score: 0Open Comment of Guidelines - 8 month(s) ago
Open comment allows for key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication.
Source: old-prod.asco.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0JNCCN 360 - Hepatobiliary - Using M7G-Linked Long Noncoding RNAs to Predict Outcomes in Hepatocellular Carcinoma - 8 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Combination treatment with camrelizumab and rivoceranib is more effective than sorafenib monotherapy in patients with previously untreated, unresectable hepatocellular carcinoma, phase 3 data suggest.
Source: www.oncologynurseadvisor.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Ionizing radiation promotes, whereas calorie restriction suppresses, NASH and hepatocellular carcinoma in mice - 9 month(s) ago
Exposure to ionizing radiation damages DNA, increasing the risk of cancer and causing concern around the use of therapeutic radiation in children. In rodents, caloric restriction reduces the incidenc…
Source: onlinelibrary.wiley.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
AbstractBackground:. Hepatocellular carcinoma (HCC) surveillance is underutilized, with <25% of individuals with cirrhosis receiving surveillance exams as recommended. The epidemiology of cirrhosis and HCC in the United States has also shifted in recent years, but little is known about recent trends in surveillance utilization. We characterized patterns of HCC surveillance by payer, cirrhosis etiology, and calendar year in insured individuals with cirrhosis.Methods:. We conducted a retrospective cohort study of individuals with cirrhosis using claims data from Medicare, Medicaid, and private insurance plans in North Carolina. We included individuals ≥ 18 years with a first occurrence of an ICD-9/10 code for cirrhosis between January 1, 2010, and June 30, 2018. The outcome was HCC surveillance by abdominal ultrasound, CT, or MRI. We estimated 1- and 2-year cumulative incidences for HCC surveillance and assessed longitudinal adherence to surveillance by computing the proportion of time c
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI: Authors study HCC surveillance by payer, #cirrhosis etiology and calendar year in insured individuals with cirrhosis and find HCC surveillance initiation after diagnosis remains low although slightly improved over time. https://t.co/qvmOYuh4Dn #HepatocellularCarcinoma https://t.co/4p0zkg1sSD
-
-
Mashup Score: 0Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL‐HBV and REVEAL‐HCV cohort studies - 9 month(s) ago
What’s new? Chronic hepatitis B or C virus (HBV/HCV) infection plays a major role in hepatocellular carcinoma (HCC) etiology in Asia. Whether gut barrier dysfunction, a risk factor for liver cancer i…
Source: onlinelibrary.wiley.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
NOW ONLINE Serum MYCN holds promise for biomarker-based precision medicine for the prevention of #HepatocellularCarcinoma (HCC), long-term prognosis of early-stage HCC & identification of high-response subgroups for acyclic retinoid-based treatment 🔓➡️https://t.co/MMZqlciqkV https://t.co/1CauXWteel